Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove (Q23917120)

NIOSHTIC-2

NIOSH Respiratory Health Division

25 September 2023

object named as

DRDS

1 reference

25 September 2023

2 references

19 July 2017

29 March 2020

2 references

19 July 2017

29 March 2020

1 reference

19 July 2017

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

11

0 references

Tasha E Fingerlin

3

object named as

Tasha E Fingerlin

0 references

author name string

Lori J Silveira

1

0 references

Erin C McCanlies

2

0 references

Michael V Van Dyke

4

0 references

Margaret M Mroz

5

0 references

Matthew Strand

6

0 references

Andrew P Fontenot

7

0 references

Natalie Bowerman

8

0 references

Dana M Dabelea

9

0 references

Christine R Schuler

10

0 references

Lisa A Maier

on focus list of Wikimedia project

12

0 references

language of work or name

English

0 references

publication date

15 October 2012

0 references

published in

Journal of Immunology

1 reference

8 December 2019

189

0 references

issue

8

0 references

page(s)

4014-23

0 references

Wikimedia–NIOSH collaboration

0 references

1 reference

2 February 2024

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Crystal structure of HLA-DP2 and implications for chronic beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Influence of MHC CLASS II in susceptibility to beryllium sensitization and chronic beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

HLA-DPB1 and chronic beryllium disease: a HuGE review

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

The natural history of beryllium sensitization and chronic beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

DNA-sequence determination of exon 2 of a novel HLA-DPB1 allele, HLA-DPB1*0403

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Interpreting borderline BeLPT results

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Molecular typing for the MHC with PCR-SSP.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Immunogenetic basis of environmental lung disease: lessons from the berylliosis model

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Peptide binding to MHC class I is determined by individual pockets in the binding groove

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Rocky Flats Beryllium Health Surveillance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Screening blood test identifies subclinical beryllium disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Optimizing BeLPT criteria for beryllium sensitization.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Beryllium sensitivity is linked to HLA-DP genotype

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347851

Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease

29 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22972925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22972925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Natural History of Beryllium Sensitization and Chronic Beryllium Disease

1 reference

Crossref

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1200798